Wang, J., Ling, S., Ni, J., & Wan, Y. (2022). Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma. BMC.
Citación estilo ChicagoWang, Jingrui, Sunbin Ling, Jie Ni, and Yafeng Wan. Novel γδ T Cell-based Prognostic Signature to Estimate Risk and Aid Therapy in Hepatocellular Carcinoma. BMC, 2022.
Cita MLAWang, Jingrui, et al. Novel γδ T Cell-based Prognostic Signature to Estimate Risk and Aid Therapy in Hepatocellular Carcinoma. BMC, 2022.
Warning: These citations may not always be 100% accurate.